Estimating Oral Anticoagulant Comparative Effectiveness in the Setting of Effect Heterogeneity: Comparing Clinical Trial Transport and Observational Epidemiologic Methods

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Administrative data (e.g. claims)

  Other
• Data sources (types), other:
  Clinical Study Data Request will be providing access to the analysis-ready dataset from the RE-LY trial of dabigatran.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No